Interpreting Next Generation Sequencing (NGS) Reports For Solid Malignancies: Unraveling Treatment Insights for Precision Medicine

August 29, 2023

- This dinner program will be a virtual (online) event. -

The advancement of genomic technology has ushered in the ability of using DNA and RNA to better understand cancer biology.  Genomic analysis is now standard of care for providing both prognostic insight into cancer behavior and predictive treatment recommendations.  Nearly all types of solid tumors and numerous hematologic malignancies include genomic analysis as part of the standard work up in the advanced disease setting with several cancer types also incorporating it into early stages as well as with evolving data.  Numerous commercial testing companies exist that provide this genomic analysis using both tumor tissue and/or blood for cell free DNA analysis.  This presentation will focus on providing a deeper comfort with next generation sequencing reports in terms of the information provided as well as using patient case examples to translate the information on the reports into treatment options for patients with diverse solid tumors.  As our ability to determine the actionability of specific genetic alterations depends on the strength of available literature, common databases and sources of literature will also be discussed in the context of patient examples.

Learning Objectives.

  1. Identify the common sections of a clinical next generation sequencing (NGS) report
  2. Formulate an individualized treatment plan for patients with solid malignancies based on findings of a NGS report
  3. Assess treatment recommendations based on the strength of the literature and patient specific characteristics

Target Audience

This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.

Presented By

                       

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 1.00 credit.
Course opens: 
06/20/2023
Course expires: 
09/29/2023
Event starts: 
08/29/2023 - 2:55pm PDT
Event ends: 
08/29/2023 - 4:30pm PDT
Cost:
$0.00
Add to calendar: 
Rating: 
0

Agenda

All Times Listed are for the Eastern Standard Time Zone

Tuesday,  August 29, 2023

5:55pmWelcome and Introduction
» Andrea Edwards, PA-C
6:00pmMeet-the-Clinician Exhibits (non-CME)
6:30pm Interpreting Next Generation Sequencing (NGS) Reports For Solid Malignancies: Unraveling Treatment Insights for Precision Medicine
» Christine M. Walko, PharmD, FCCP, BCOP - Moffitt Cancer Center
7:30pmClosing Comments
» Andrea Edwards, PA-C
7:35pmExhibits (non-CME)
Online - Virtual Event
United States

Faculty

Andrea Edwards, PA-C (Moderator)

Andrea has been practicing as a Hematology/Oncology Physician Assistant since 2011. She previously completed a year of practice in Orthopedics before joining VOA. She works alongside VOA physicians with a special focus on breast cancer, among other cancers. She played an integral role in the development of the survivorship program. 

Andrea serves as supervisor of the VOA Advanced Practice Providers. She is a member of the Virginia Association of Physician Assistants, the American Academy of Physician Assistants, and the Association of Physician Assistants in Oncology. Outside of medicine, Andrea enjoys spending time with her family and friends. 

 

Christine Walko, PharmD, FCCP, BCOP (Speaker)                                            

Christine M. Walko graduated with her Pharm.D. degree from Duquesne University in Pittsburgh, Pennsylvania, and completed a pharmacy practice residency at the Medical College of Virginia/VCU in Richmond, Virginia, and a hematology/oncology specialty residency at the University of North Carolina (UNC). She stayed at UNC to complete a 2-year academic oncology fellowship focused on drug metabolism and translational research before taking an assistant professor position at UNC in the Division of Pharmacotherapy and Experimental Therapeutics.

Dr. Walko is now a Senior Member in the Department of Individualized Cancer Management, Team Lead for Precision Medicine and Attending for the Personalized Medicine Clinical Service.  She also serves on the ASCO TAPUR Molecular Tumor Board. Her research focus is on optimizing drug therapy using pharmacogenomics and pharmacokinetics to personalize intravenous and oral anticancer therapy for patients with cancer.

Disclosures:

Horizon CME requires all planners, faculty, and other contributors to disclose any financial relationships with an ACCME defined ineligible company within the past 24 months and Horizon CME has resolved any conflicts prior to this educational activity.

Christine Walko, PharmD, FCCP, BCOP  discloses she has a consulting fee with Jackson Genetic Laboratories, during the past 24 months.   

Andrea Edwards, PA-C discloses she had relationship as Advisory Board with GI Therapeutics, but that relationship ended, she disclosed other with APSHO, professional Development Leadership Group, during the past 24 months.

All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 1.00 credit.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above


Supported Phones & Tablets:

Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above